Werewolf Therapeutics
Watertown, US · Founded 2017 · Delaware corporation · 6 known investors
Werewolf Therapeutics is a biotechnology company developing immunotherapy treatments for cancer. The company focuses on leveraging immune modulation and innovative therapeutic approaches in oncology.
Founders & leadership
Werewolf Therapeutics was founded in 2017 by Daniel J. Hicklin, Luke Evnin, and Daniel Hicklin.
DJ
Daniel J. HicklinFounder, President, Chief Executive Officer, and Board memberManaging Partner at MPM Capital
LE

DH
DC
David CordoExecutive
AL
Alon LazarusNamed on SEC filing
Board
CW

BM

SA

Investors · 6
Reported raises · per SEC filings
Form D private placements$128.2M disclosed across 2 rounds · 2019–2020
▶$72.1MraisedJan 2021 · 19 investors · PharmaceuticalsRule 506(b)
▶$72.1MraisedJan 2021 · 19 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Luke EvninDirector
- Briggs MorrisonDirector
- Daniel HicklinExecutive Officer, Director
- Sakae AsanumaDirector
- Alon LazarusDirector
- Elise WangDirector
- David CordoExecutive Officer
- Derek DiRoccoDirector
- Offering amount
- $72.1M
- Amount sold
- $72.1M
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$56.2MraisedAug 2020 · 10 investors · PharmaceuticalsRule 506(b)
▶$56.2MraisedAug 2020 · 10 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Luke EvninDirector
- Daniel HicklinExecutive Officer, Director
- Alon LazarusDirector
- David CordoExecutive Officer
- Christoph WestphalDirector
- Briggs MorrisonDirector
- Sakae AsanumaDirector
- Offering amount
- $56.2M
- Amount sold
- $56.2M
- First sale
- Aug 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Werewolf Therapeutics went on to found or lead other companies.
Competitors · 5
by search overlapPerplexity14 shared keywordsAn AI-powered answer engine providing accurate, trusted, and real-time answers to questions.
Seeking Alpha12 shared keywordsSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
StockTwits12 shared keywordsStocktwits is a social platform for investors and traders to share market news, discussions, sentiment polls, and live financial content. It aggregates breaking market news, equity coverage, and community discussions around individual stocks and crypto.
Simply Wall St12 shared keywordsSimply Wall St is a stock analysis platform that provides portfolio insights, stock discovery tools, and market alerts for individual investors. The service offers institutional-grade financial data visualization and analysis across 120,000 global stocks.
Grey Wolf Therapeutics11 shared keywordsGreywolf is a clinical-stage biotech developing antigen modulation therapies, including oral small molecules in Phase 1/2 trials, for people with cancers and autoimmune disorders.
Companies competing with Werewolf Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Werewolf Therapeutics do?
- Werewolf Therapeutics is a biotechnology company developing immunotherapy treatments for cancer. The company focuses on leveraging immune modulation and innovative therapeutic approaches in oncology.
- Who founded Werewolf Therapeutics?
- Werewolf Therapeutics was founded by Daniel J. Hicklin, Luke Evnin, Daniel Hicklin in 2017.
- Who are Werewolf Therapeutics's investors?
- Werewolf Therapeutics's investors include DC Investment Partners, K2 HealthVentures, Longwood Fund, MPM BioImpact, RA Capital, Taiho Ventures, LLC.
- How much funding has Werewolf Therapeutics raised?
- Werewolf Therapeutics has disclosed $128.2M raised across 2 rounds.
- Where is Werewolf Therapeutics headquartered?
- Werewolf Therapeutics is headquartered in Watertown, US.


